Second Covid-19 Vaccine Approved by Russia

United States News News

Second Covid-19 Vaccine Approved by Russia
United States Latest News,United States Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

Russia approved a second coronavirus vaccine as it tries to cement its role as a major player in the race to end the pandemic—despite skepticism from scientists and Western politicians over the speed with which its first vaccine was developed

MOSCOW—Russia approved a second Covid-19 vaccine and said it was closing in on a third as Moscow attempts to establish itself as a major player in the global race to end the coronavirus pandemic.

Russian President Vladimir Putin said Wednesday that a vaccine developed by Vector State Virology and Biotechnology Center, a former Soviet bioweapons research lab, has received regulatory approval. Russian officials said that a third vaccine could be approved in December.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Russia approves second COVID-19 vaccine after preliminary trialsRussia approves second COVID-19 vaccine after preliminary trialsRussia has granted regulatory approval to a second COVID-19 vaccine, according to its register of authorised medicines.
Read more »

2nd COVID-19 vaccine trial paused over unexplained illness2nd COVID-19 vaccine trial paused over unexplained illnessA late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot
Read more »

Johnson & Johnson Paused Trials on Its COVID-19 Vaccine Due to Subject's 'Unexplained Illness'Johnson & Johnson Paused Trials on Its COVID-19 Vaccine Due to Subject's 'Unexplained Illness'Johnson & Johnson started Phase 3 human trials on a COVID-19 vaccine in September, and it was paused a month later due to a participant's illness.
Read more »

Fauci says Covid-19 vaccine development 'on a really good track'Fauci says Covid-19 vaccine development 'on a really good track'Dr. Anthony Fauci, the nation's leading infectious disease expert, said current efforts toward Covid-19 vaccine development are “on a really good track” despite news that a second vaccine was put on hold this week
Read more »

'Safe and effective' Covid-19 vaccine may be widely available by April 2021, Fauci says'Safe and effective' Covid-19 vaccine may be widely available by April 2021, Fauci saysThe coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
Read more »



Render Time: 2025-03-12 15:25:28